Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin - Related Studies

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

This study is currently recruiting participants.

Study NCT00453050. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma (Skin)
		Metastatic Cancer

2	Additional conditions recognized in this trial
		Melanoma
		Neoplasm Metastasis

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neoplastic Processes
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Pathologic Processes

4	Interventions listed in this trial
		imiquimod
		indocyanine green solution
		flow cytometry
		immunologic technique
		laboratory biomarker analysis

5	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Antineoplastic Agents
		Immunologic Factors
		Interferon Inducers
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Oklahoma Health Sciences Center - Tulsa